Companies /Healthcare

Aytu BioScience Inc

NASDAQ: AYTU Drug Manufacturers - Specialty & Generic
$2.04
▲ $0.03 (+1.49%) today
Markets closed · 5:19pm ET

AYTU at a Glance

Valuation
Market cap
$21.8M
Profitability
Revenue (TTM)
$57.6M
Profit margin
-24.8%
EPS (TTM)
$-1.16
Price
52-week range
$2 – $3
Street target
$9.67
Earnings
Next report
Nov 12, 2026

Headquartered in Denver, CO Fiscal year ends June NASDAQ: AYTU aytubio.com

About Aytu Biopharma

Aytu BioPharma is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases. Its flagship product is EXXUA (gepirone extended-release tablets), a novel oral selective serotonin 5-HT1A receptor agonist indicated for the treatment of major depressive disorder (MDD) in adults, targeting the over $22 billion U.S. prescription MDD market. The company also markets a portfolio of ADHD treatments and pediatric products. Aytu delivers its medications through patient access programs designed to support optimal patient outcomes and commercializes its products through an internal sales force and channel distribution partners. The company trades on Nasdaq under the ticker AYTU. Updated

Latest Activity

Earnings on deck — Sep 21–25
24 companies14 before open10 after close

Tuesday and Wednesday carry the week: AutoZone, KB Home, General Mills, Paychex and Cintas all report inside 48 hours, covering car repair budgets, new home demand, grocery pricing and small business payrolls in one stretch. Of the 24 companies on deck, 14 report before the open.

  • ABVXABIVAX Société AnonymeMon Sep 21After close
  • THOTHOR Industries, Inc.Tue Sep 22Before open
  • AZOAutoZone, Inc.Tue Sep 22Before open
  • MLKNMillerKnoll, Inc. Tue Sep 22Before open
  • HEREHere Group LimitedTue Sep 22Before open
  • KBHKB HomeTue Sep 22After close
  • WORWorthington Enterprises, Inc.Tue Sep 22After close
  • AYTUAytu BioPharma, Inc.Tue Sep 22After close
  • CBRLCracker Barrel Old Country Store, Inc.Wed Sep 23Before open
  • GISGeneral Mills, Inc.Wed Sep 23Before open
  • PAYXPaychex, Inc.Wed Sep 23Before open
  • CTASCintas CorporationWed Sep 23Before open
  • MANUManchester UnitedWed Sep 23Before open
  • FULH.B. Fuller CompanyWed Sep 23After close
  • SFIXStitch Fix, Inc.Wed Sep 23After close
Read more

AYTU Coverage

10:45am ET
Health and Healthcare

Can Atyu Bioscience Deliver on COVID-19 Treatments?

Aytu Bioscience has moved very quickly, both to execute agreements for products that can have an impact on the COVID-19 pandemic and to raise the capital it will take to provide a…

AYTU
Paul Ausick
7:31am ET
Health and Healthcare

Aytu BioScience Stock: Developments in Denver

Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.

AYTU BDX CODX
Chris Lange
10:11am ET
Health and Healthcare

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.

AYTU DGX GILD
Chris Lange

Frequently Asked Questions

What does Aytu Biopharma do?

Aytu BioPharma is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system (CNS) diseases.

What is the AYTU stock price target?

The Wall Street consensus 12-month price target for AYTU is $9.67.